Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients. The gene discussed is FTH1; the disease is early-onset autosomal dominant Alzheimer disease.